StockData

Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.31−0.68 (-17.04%)

Close on Nov 17, 2026Market cap $30.72MP/E –Yield –

Exozymes cash

Cash and short-term investments held at the end of each period.

Exozymes's cash was $3.26M at Sep 30, 2026. For fiscal 2025 it was $3.04M, down 68.7% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.04M-68.7%
FY2024Dec 31, 2024$9.72M+14508.3%
FY2023Dec 31, 2023$66.53K-88.1%
FY2022Dec 31, 2022$558.57K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.26M-36.1%
Q2 FY2026Jun 30, 2026$5.65M-19.1%
Q1 FY2026Mar 31, 2026$1.44M-83.0%
Q4 FY2025Dec 31, 2025$3.04M-68.7%
Q3 FY2025Sep 30, 2025$5.10M+2079.5%
Q2 FY2025Jun 30, 2025$6.99M+4314.8%
Q1 FY2025Mar 31, 2025$8.51M+7379.6%
Q4 FY2024Dec 31, 2024$9.72M+14508.3%
Q3 FY2024Sep 30, 2024$233.94K-50.7%
Q2 FY2024Jun 30, 2024$158.24K-71.7%
Q1 FY2024Mar 31, 2024$113.80K–
Q4 FY2023Dec 31, 2023$66.53K–
Q3 FY2023Sep 30, 2023$474.56K–
Q4 FY2022Dec 31, 2022$558.57K–

More Exozymes figures

See a number that looks wrong?